Literature DB >> 11407107

Cardiovascular drug-drug interactions.

J R Anderson1, J J Nawarskas.   

Abstract

The drug-drug interactions discussed in this article have either documented or suspected clinical relevance for patients with cardiovascular disease and the clinician involved in the care of these patients. Oftentimes, drug-drug interactions are difficult, if not impossible, to predict because of the high degree of interpatient variability in drug disposition. Certain drug-drug interactions, however, may be avoided through knowledge and sound clinical judgment. Every clinician should maintain a working knowledge of reported drug-drug interactions and an understanding of basic pharmacokinetic and pharmacodynamic principles to help predict and minimize the incidence and severity of drug-drug interactions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11407107     DOI: 10.1016/s0733-8651(05)70209-5

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  3 in total

1.  Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.

Authors:  Silvia-Regina Secoli; Albert Figueras; Maria Lúcia Lebrão; Fernão Dias de Lima; Jair Licio Ferreira Santos
Journal:  Drugs Aging       Date:  2010-09-01       Impact factor: 3.923

Review 2.  Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.

Authors:  Shufeng Zhou; Sui Yung Chan; Boon Cher Goh; Eli Chan; Wei Duan; Min Huang; Howard L McLeod
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

3.  Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4.

Authors:  Shufeng Zhou; Eli Chan; Xiaotian Li; Min Huang
Journal:  Ther Clin Risk Manag       Date:  2005-03       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.